天宇股份盐酸曲唑酮片获药品注册证书

Core Viewpoint - Tianyu Co., Ltd. announced that its wholly-owned subsidiary, Zhejiang Nuode Pharmaceutical Co., Ltd., has received the drug registration certificate for Clomipramine Hydrochloride Tablets from the National Medical Products Administration, valid until December 15, 2030, indicating a significant advancement in its product portfolio for treating depression [1] Group 1 - The drug is indicated for the treatment of depression, effective for patients with or without anxiety [1]